Neuroscience Research
Neuroscience is the study of the nervous system - one of the major mammalian systems responsible for sustaining life. The central nervous system (CNS) and peripheral nervous system (PNS) work in concert to coordinate basic functions such as moving and breathing, as well as 'higher order' functions including thought, speech and emotion.
Neuroscience Research Products Areas
- Stress and Anxiety Research (392)
- Nociception (957)
- Neurotransmission (892)
- Neuropeptides (43)
- Neural Development (795)
- Memory, Learning and Cognition (746)
- Blood-Brain Barrier (119)
- Stroke Research (665)
- Sleep Research (267)
- Schizophrenia Research (709)
- Parkinson's Disease Research (752)
- Huntington's Disease Research (465)
- Epilepsy Research (560)
- Depression Research (631)
- Alzheimer's Disease Research (399)
- Addiction Research (509)
- Multiple Sclerosis (419)
Products for Neuroscience Research - Page 52
- Cat.No. Product Name Information/Activity
-
BCC5883
PDZ1 Domain inhibitor peptide
1315378-73-4
-
BCC4773
Cyclosporin A
Cyclosporin A is an immunosuppressant which binds to the cyclophilin and inhibits phosphatase activity of calcineurin with an IC50 of 5 nM. Cyclosporin A also inhibits CD11a/CD18 adhesion.
-
BCC5288
TRO 19622
Olesoxime (TRO 19622) is a mitochondrial-targeted neuroprotective compound with mean EC50 value for increasing cell survival is 3.2±0.2 µM.
-
BCC7952
Auranofin
Auranofin (SKF-39162) is a thioredoxin reductase (TrxR) inhibitor with an IC50 of 0.2 μM.
-
BCC6566
cis-ACPD
477331-06-9
-
BCC2894
H-D-Asp-OH
(-)-Aspartic acid is an endogenous NMDA receptor agonist.
-
BCC2881
H-Asp-OH
L-Aspartic acid is is an amino acid, shown to be a suitable prodrug for colon-specific drug deliverly.
-
BCC6571
L-Cysteinesulfinic acid
L-Cysteinesulfinic acid is a potent agonist at several rat metabotropic glutamate receptors (mGluRs) with pEC50s of 3.92±0.03, 4.6±0.2, 3.9±0.2, 2.7±0.2, 4.0±0.2, and 3.94±0.08 for mGluR1, mGluR5, mGluR2, mGluR4, mGluR6, and mGluR8, respectively.
-
BCC6013
GLYX 13
Rapastinel (GLYX-13) is an N-methyl-D-aspartate receptor (NMDAR) modulator that has characteristics of a glycine site partial agonist.
-
BCC6588
(R)-(+)-HA-966
(R)-(+)-HA-966 ((+)-HA-966) is a partial agonist/antagonist of glycine site of the N-methyl-D-aspartate (NMDA) receptor complex. (R)-(+)-HA-966 selectively blocks the activation of the mesolimbic dopamine system by amphetamine. (R)-(+)-HA-966 can cross the blood-brain barrier and has the potential for neuropathic and acute pain.


